Medimaps Group is the furture of routine osteoporosis bone health screening with TBS Osteo

The future of routine osteoporosis bone health screening is right around the corner

TBS Osteo is powered by TBS iNsight our medically
approved product, the gold standard in bone microarchitecture
assessment on DXA in osteoporosis.

Learn more »

Bone quality assessment
for surgical implants and procedures.
Under development.

Learn more »

Supporting healthcare professionals in improving patient management, identifying more patients at risk of fracture and
fine-tuning therapy decisions

+60

COUNTRIES

in which TBS Osteo is commercially present

+2M

PROCEDURES

more than 2 million TBS procedures worldwide

+30

GUIDELINES

TBS is recommended nationally & internationally

Our latest news

ECR Workshop recording now available!

Medimaps Group presents new AI results at ECR 2023

SEE ALL NEWS

Our partners

TBS iNsight serves as a foundation technology for tissue structure assessment software applications.

Leveraged first in the field of osteoporosis as the gold standard for bone microarchitecture assessment on DXA in osteoporosis – making a difference in patient lives.

Used in daily clinical routine in osteoporosis. Ongoing research shows its applicability in other medical fields.

TBS iNsight™ is a Medical Device that is CE 2797 (BSI) marked (cert. 715499) & 510(k) K152299 cleared in the US

Supporting healthcare professionals in improving patient management, identifying more patients at risk of fracture and fine-tuning therapy decisions

+60